Disparities in Female Oncofertility Care in the United States: More Questions Than Answers

Kati A. Turner, Emily E. Spurlin, Patricia T. Jimenez

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


As cancer therapies continue to improve, the survival rates of adolescent and young adult patients have increased. Consequently, considering patient quality of life after cancer, including family building, has become an essential aspect of establishing a treatment plan. However, the gonadotoxic nature of many chemotherapeutic agents limits the option of using one’s own gamete for family building. In recent years, significant advancements have been made in oncofertility, particularly vitrification of oocytes. Unfortunately, as with many areas of medicine, health disparities limit those that can access and utilize fertility preservation prior to cancer treatment. This review aims to shed light on existing disparities in oncofertility for female patients, to offer recommendations to enhance education, access, and advocacy, as well as identify potential areas for future research.

Original languageEnglish
Article number1547
Issue number7
StatePublished - Jul 2023


  • fertility preservation
  • health disparities
  • oncofertility


Dive into the research topics of 'Disparities in Female Oncofertility Care in the United States: More Questions Than Answers'. Together they form a unique fingerprint.

Cite this